Short FDA inspection preparation guides
Build readiness in focused steps. Browse descriptions freely, then sign in for the complete brief. These independent training briefs are not official FDA inspection guides.
Short, focused preparation briefs with source context, records to retrieve, questions to discuss, and a practical exercise. Browse descriptions publicly; create a free account to read the complete briefs.
Matching readings
8 readings in this view.
In vitro diagnostics · Packaging & labeling
IVD point-of-care kits: trace the label through a use scenario
Compare the marketed intended user and setting with the kit, instructions, storage information, and studied use. Do not equate point-of-care use with an automatic CLIA waiver.
Sign in to read →In vitro diagnostics · Testing & laboratory work
IVD hematology: define the instrument and reagent configuration
Review the configuration used for a specific evaluation, its reagent and control identities, maintenance status, and retained evidence. Keep a demonstration separate from a clinical performance claim.
Sign in to read →In vitro diagnostics · Testing & laboratory work
IVD clinical chemistry: follow a reagent lot transition
Examine the planned change from one reagent lot to another, the supporting evaluation, acceptance rationale, and traceability. Use the product-specific process rather than a universal comparison rule.
Sign in to read →In vitro diagnostics · Testing & laboratory work
IVD molecular testing: trace reagent, run, and result interpretation
Follow a training run through specimen or control identity, reagent lot, instrument configuration, acceptance decisions, and interpretation. Use the product’s intended use and instructions; this is not a clinical testing protocol.
Sign in to read →In vitro diagnostics · Testing & laboratory work
IVD immunoassays: connect calibrators and controls to the reported decision
Map the relationship among calibrator identity, control results, reagent lot, instrument status, and the reportable use. Do not infer clinical acceptance limits from this brief.
Sign in to read →In vitro diagnostics · Packaging & labeling
Label reconciliation: explain a count discrepancy
Trace issued, used, returned, and rejected labels against the site’s approved reconciliation method. Do not invent an acceptable discrepancy or treat a count as proof that every label was correct.
Sign in to read →In vitro diagnostics · Incoming materials
IVD reagent lots: connect the label to the production history
Trace a reagent lot through components, production, testing, label version, release, and distribution. Keep the intended use and product-specific quality-system requirements in scope.
Sign in to read →In vitro diagnostics · Computerized systems
Electronic records: trace access, change, and review
Follow the electronic record through creation, authorized use, changes, retention, and retrieval. Establish which regulatory requirements apply to the record before making a Part 11 applicability claim.
Sign in to read →Keep learning
Inspection guides · In the Warroom · Virtual immersive inspections · Industry reading clubs · Programs & interest signups
Industry learning clusters
- Contract laboratory learning cluster
- Laboratory learning cluster
- Pharmaceutical learning cluster
- Medical device learning cluster
- IVD learning cluster
- Biologics, blood and cell learning cluster
- Cosmetics learning cluster
- Dietary supplement learning cluster
- Food learning cluster
- Animal health learning cluster
- Clinical research learning cluster